AstraZeneca’s $2 Billion Maryland Expansion Raises Big Questions for U.S. Biotech
WILMINGTON, DE — AstraZeneca (NASDAQ: AZN) announced plans to invest $2 billion to expand its manufacturing footprint in Maryland, marking the company’s fourth major U.S. commitment this year and advancing …
AstraZeneca’s $2 Billion Maryland Expansion Raises Big Questions for U.S. Biotech Read More